Clinical trials
Phase 1 Small Cell Lung Carcinoma trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2017 | 3 |
| 2019 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 1 |
| Astellas Pharma Inc | 1 |
| BeiGene | 1 |
| Boehringer Ingelheim | 1 |
| Cancer Research UK | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Eli Lilly and Company | 1 |
| GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 1 |
| GlaxoSmithKline | 1 |
| ImmunoGen, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 14 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Ovarian Neoplasms | 5 |
| Stomach Neoplasms | 5 |
| Colorectal Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Carcinoma, Renal Cell | 3 |
| Esophageal Squamous Cell Carcinoma | 3 |
| Neoplasm Metastasis | 3 |
| Pancreatic Neoplasms | 3 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.